Marrone Bio Innovations, Inc

110 articles with Marrone Bio Innovations, Inc

• Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered

  1/5/2021

  Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions. Effective Dec. 29, 2020, an amendment was made to a prior warrant agreement with Van Herk Investments that extends the maturities of its existing warrants. As a result, Van Herk exercised 33.3% of its outstanding warrants, reducing the tot

• Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration StatementNo Offer of New Securities; Registration Statement Permits Resale of Common Stock from Warrant Financing Exercises

  1/5/2021

  Marrone Bio Innovations, Inc. (Nasdaq:  MBII ) (MBI),  a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Form S-3 resale registration statement relating to the potential resale of shares of common stock, including common stock issuable upon the exercise of warrants held by certain shareholders per the Company’s previously announced warrant transaction, has been d

• PGG Wrightson Seeds to Distribute Marrone Bio Innovations’ Pro Farm UBP Seed Treatment in Uruguay

  12/21/2020

  Farmers in Uruguay will have a new solution to grow a more sustainable crop thanks to a new arrangement that will allow PGG Wrightson Seeds, New Zealand’s largest seed company, to distribute Marrone Bio Innovations, Inc.’s line of Pro Farm Technology products.

• Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results

  11/9/2020

  Expansion in international and seed treatment markets led revenue growth and gross margin improvement

• Marrone Bio Innovations Issues Shareholder Letter and Provides Operational Update

  10/19/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash. Dear Shareholders: As we close the third quarter, I wanted to take the opportunity to provide you with an update on our business and the steps we are taking to

• Marrone Bio Innovations Announces Plans for CFO SuccessionPresident and CFO James Boyd to Retire from the Company; Search Process for New CFO Underway

  9/22/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that company President and Chief Financial Officer James Boyd will retire from his positions. A national search process for the new Chief Financial Officer is underway, and Mr. Boyd will continue as President and CFO during the

• Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference

  9/10/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference taking place virtually September 14 – 16, 2020. Jim Boyd, Chief Financial Officer, is scheduled to host a virtual pre

• Marrone Bio Innovations to Present at LD Micro 500 Virtual Investor Conference

  8/20/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020. Jim Boyd, Chief Financial Officer of Marrone Bio, is scheduled to host

• Marrone Bio Innovations, Inc. Reports Second Quarter and First Half 2020 Financial Results

  8/10/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, has provided its financial results for the second quarter ended June 30, 2020.

• Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers

  8/6/2020

  Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, and Vive Crop Protection, a leader in Precision Chemistry solutions and owner of the patented Allosperse® technology, announced an agreement that will provide a suite of ground-breaking products for U.S. growers that combine a leading biological with proven conventional chemistry utilizing the unique Allosperse Delivery System.

• Marrone Bio Innovations to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th

  8/4/2020

  Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place August 11 to 13, 2020. Jim Boyd, Chief Financial Officer, is scheduled to host a virtual presentation duri

• Marrone Bio Innovations to Report Second Quarter 2020 Results on Monday, August 10th at 4:30 p.m. Eastern TimeCompany Concurrently Confirms August 3rd Start Date for Incoming Chief Executive Officer and Director Kevin Helash

  7/24/2020

  Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the second quarter ended June 30, 2020, after market close on Monday, August 10th at 4:30 pm Eastern time. The company also announced that incoming Chief Executive Officer Kevin Helash, a Canadian citizen, has  received his vi

• Marrone Bio Appoints Kevin Helash as Chief Executive OfficerAgricultural Industry Veteran Brings Extensive Experience in Global Markets and Biological Solutions

  7/6/2020

  Marrone Bio Innovations, Inc., (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to global agricultural needs, today announced the appointment of Kevin Helash as its new chief executive officer

• Marrone Bio Innovations’ Regalia® is Top Biofungicide Brand in CaliforniaNewly Approved Stargus® Expands Company Footprint

  6/24/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its flagship biofungicide, Regalia, holds more than 25% market share* of the foliar biofungicide segment in California; outperforming direct competitors during January through April 2020. “Regalia’s performance is a testament to its efficacy for managing plant diseases and improving crop heal

• Marrone Bio Innovations Regains Compliance with Nasdaq Minimum Bid Price Requirement

  6/22/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that it received notice from The Nasdaq Stock Market, LLC ("Nasdaq") on June 19, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. “We are pleased to announce to o

• Marrone Bio Innovations and UPL Sign Exclusive Distribution Agreement for REGALIA® MAXX in the Republic of South Africa

  6/9/2020

  Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, announced the signing of an exclusive commercial agreement with UPL to distribute REGALIA® MAXX Fungicide in the Republic of South Africa.

• Marrone Bio Innovations to Present at the June 2020 Virtual Investor Summit

  5/26/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020. Marrone Bio Innovations management will host virtual one-on-one investor meetings throughout the event and is scheduled to present as follows: Virtual Investor Summit               Date: Tuesday, June 9,

• Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada

  5/14/2020

  Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that REGALIA ® MAXX biofungicide received the first approval for indoor and outdoor use on cannabis and hemp in Canada. Cannabis and hemp have been relatively small crops in Canada until lifestyle cannabis was approved in 2018. According to Health Canada, 77,800 acres of hemp were grown in 2018,

• Marrone Bio Innovations, Inc. Reports First Quarter 2020 Financial Results

  5/11/2020

  Record Revenues; Seventh Consecutive Quarter of Year Over Year Revenue Growth Realized in Challenging Environment for Agricultural Production

• Marrone Bio Innovations to Report First Quarter 2020 Results on Monday, May 11th at 4:30 p.m. Eastern Time

  5/1/2020

  Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, will release financial results for the first quarter ended March 31, 2020, after market close on Monday, May 11 th  at 4:30pm Eastern time. Management will host an investor conference call at 1:30 p.m. PST (4:30 p.m. EDT) on May 11, 2020 to discuss Marrone Bio Innovations’ first quarter 2020 financial results, provide a